collection
MENU ▼
Read by QxMD icon Read
search

DAPT

shared collection
7 papers 0 to 25 followers
By Alessandro Iadanza Interventional Cardiologist at Siena University Hospital
https://www.readbyqxmd.com/read/27036918/2016-acc-aha-guideline-focused%C3%A2-update-on-duration-of-dual%C3%A2-antiplatelet-therapy-in-patients-with-coronary-artery-disease-a-report-of-the-american-college-of-cardiology-american-heart-association-task%C3%A2-force%C3%A2-on%C3%A2-clinical-practice-guidelines
#1
Glenn N Levine, Eric R Bates, John A Bittl, Ralph G Brindis, Stephan D Fihn, Lee A Fleisher, Christopher B Granger, Richard A Lange, Michael J Mack, Laura Mauri, Roxana Mehran, Debabrata Mukherjee, L Kristin Newby, Patrick T O'Gara, Marc S Sabatine, Peter K Smith, Sidney C Smith
No abstract text is available yet for this article.
September 6, 2016: Journal of the American College of Cardiology
https://www.readbyqxmd.com/read/27036919/duration-of-dual-antiplatelet-therapy-a-systematic-review-for-the-2016-acc-aha-guideline-focused-update-on-duration-of-dual-antiplatelet-therapy-in-patients-with-coronary%C3%A2-artery-disease-a-report-of-the-american-college-of-cardiology-american-heart-association
#2
John A Bittl, Usman Baber, Steven M Bradley, Duminda N Wijeysundera
BACKGROUND: The optimal duration of dual antiplatelet therapy (DAPT) after implantation of newer-generation drug-eluting stents (DES) remains uncertain. Similarly, questions remain about the role of DAPT in long-term therapy of stable post-myocardial infarction (MI) patients. AIM: Our objective was to compare the incidence of death, major hemorrhage, MI, stent thrombosis, and major adverse cardiac events in patients randomized to prolonged or short-course DAPT after implantation of newer-generation DES and in secondary prevention after MI...
September 6, 2016: Journal of the American College of Cardiology
https://www.readbyqxmd.com/read/27026020/2016-acc-aha-guideline-focused-update-on-duration-of-dual-antiplatelet-therapy-in-patients-with-coronary-artery-disease-a-report-of-the-american-college-of-cardiology-american-heart-association-task-force-on-clinical-practice-guidelines-an-update-of-the-2011
#3
https://www.readbyqxmd.com/read/26965534/platelet-inhibition-with-ticagrelor-60-mg-versus-90-mg-twice-daily-in-the-pegasus-timi-54-trial
#4
RANDOMIZED CONTROLLED TRIAL
Robert F Storey, Dominick J Angiolillo, Marc P Bonaca, Mark R Thomas, Heather M Judge, Fabiana Rollini, Francesco Franchi, Arif J Ahsan, Deepak L Bhatt, Julia F Kuder, Philippe Gabriel Steg, Marc Cohen, Rangasamy Muthusamy, Eugene Braunwald, Marc S Sabatine
BACKGROUND: The PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients with Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis In Myocardial Infarction 54) trial studied 2 doses of ticagrelor, 90 mg twice a day (bid) and 60 mg bid, for long-term prevention of ischemic events in patients with prior myocardial infarction. Both doses similarly reduced the rate of ischemic events versus placebo. The pharmacokinetics and pharmacodynamics of ticagrelor 60 mg bid have not been studied...
March 15, 2016: Journal of the American College of Cardiology
https://www.readbyqxmd.com/read/25761893/duration-of-dual-antiplatelet-therapy-after-drug-eluting-stent-implantation-will-we-ever-reach-a-consensus
#5
EDITORIAL
Marco Valgimigli, Sara Ariotti, Francesco Costa
No abstract text is available yet for this article.
May 21, 2015: European Heart Journal
https://www.readbyqxmd.com/read/25681754/duration-of-dual-antiplatelet-therapy-after-drug-eluting-stent-implantation-a-systematic-review-and-meta-analysis-of-randomized-controlled-trials
#6
REVIEW
Gennaro Giustino, Usman Baber, Samantha Sartori, Roxana Mehran, Ioannis Mastoris, Annapoorna S Kini, Samin K Sharma, Stuart J Pocock, George D Dangas
BACKGROUND: The optimal duration of dual antiplatelet therapy (DAPT) after drug-eluting stent (DES) implantation is unclear, and its risks and benefits may vary according to DES generation. OBJECTIVES: The goal of this study was to evaluate the efficacy and safety of DAPT after DES implantation. METHODS: We included randomized controlled trials that tested different durations of DAPT after DES implantation: shorter dual antiplatelet therapy (S-DAPT) was defined as the per-protocol minimum duration of DAPT after the procedure, and longer dual antiplatelet therapy (L-DAPT) was defined as the per-protocol period of more prolonged DAPT...
April 7, 2015: Journal of the American College of Cardiology
https://www.readbyqxmd.com/read/25403595/pretreatment-with-p2y12-inhibitors-in-non-st-segment-elevation-acute-coronary-syndrome-is-clinically-justified
#7
REVIEW
Marco Valgimigli
No abstract text is available yet for this article.
November 18, 2014: Circulation
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"